Cargando…
Long-term Survival of a Patient with Small Cell Lung Cancer Secreting ADH and ACTH Simultaneously, Following the Prolonged Use of Amrubicin
Paraneoplastic syndromes are frequently observed in lung cancer, especially in small cell lung cancer (SCLC). Although there have been many reports on paraneoplastic syndromes, few reports have been published on SCLC that simultaneously produces antidiuretic hormone (ADH) and adrenocorticotropic hor...
Autores principales: | Kosuda, Aya, Shirahata, Toru, Kudo, Nasa, Uehara, Yuki, Miyawaki, Masayoshi, Hagiwara, Aika, Murakami, Rie, Shimizu, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995698/ https://www.ncbi.nlm.nih.gov/pubmed/31511478 http://dx.doi.org/10.2169/internalmedicine.2838-19 |
Ejemplares similares
-
Pneumothorax triggered by the combination of gefitinib and amrubicin and treated with endobronchial silicone spigots
por: Imamura, Fumio, et al.
Publicado: (2015) -
ADH IB Expression, but Not ADH III, Is Decreased in Human Lung Cancer
por: Mutka, Sarah C., et al.
Publicado: (2012) -
Amrubicin Monotherapy for Patients with Platinum-Refractory Gastroenteropancreatic Neuroendocrine Carcinoma
por: Ando, Takayuki, et al.
Publicado: (2015) -
Tumor‐selective Distribution of an Active Metabolite of the 9‐Aminoanthracycline Amrubicin
por: Noguchi, Toshihiro, et al.
Publicado: (1998) -
Beyond the Dual Paraneoplastic Syndromes of Small-Cell Lung Cancer with ADH and ACTH Secretion: A Case Report with Literature Review and Future Implications
por: Agarwal, Krishna Adit, et al.
Publicado: (2018)